Rong Hu

Rong Hu

Auto-generated profile, based on publicly available information

Rong Hu

Department of Ophthalmology, The First Hospital of Hunan University of Chinese Medicine, Changsha, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2025 in Global Challenges
Verified
Journal Article
Open access
RHRong Hu
Rong Hu
JSJian Shi
Jian Shi
CXCan‐Ming Xie
Can‐Ming Xie
XYXiaolei Yao
Xiaolei Yao
Dry eye disease (DED), a multifactorial ocular surface disorder characterized by tear film instability, is pathologically linked to oxidative damage. The accumulation of reactive oxygen species (ROS) across ocular tissues not only directly damages nucleic acids, proteins, and lipids, but also functions as an upstream driver of inflammation and tear hyperosmolarity, collectively disrupting cellular homeostasis. This review comprehensively delineates the mechanistic interplay between oxidative stress (OS) and DED pathogenesis, synthesizing evidence on enzymatic/ nonenzymatic antioxidant alterations in samples of corneal, lacrimal, conjunctival, meibomian gland, and tear tissues, alongside quantitative profiling of OS biomarkers, such as 4‐hydroxynonenal (4HNE), malondialdehyde (MDA), 8‐hydroxy‐2′‐deoxyguanosine (8‐OHdG), and 3‐nitrotyrosine (3‐NT). Furthermore, the therapeutic mechanisms of clinically approved and investigational antioxidants, including SKQ1, rebamipide, mitoquinone, elamipretide, lactoferrin, nanozymes, graphene quantum dots, tetrahedral frame of nucleic acids, and Chinese medicine monomers are critically evaluated. With the changes in the modern social environment and lifestyle, the influence of OS on DED is gradually expanding. Antioxidant‐based interventions are poised to become cornerstone components of multimodal DED management strategies.

6 February 2025 in Animal Models and Experimental Medicine
Verified
Journal Article
Open access
RHRong Hu
Rong Hu
KWKai Wu
Kai Wu
JSJian Shi
Jian Shi
JYJuan Yu
Juan Yu
XYXiaolei Yao
Xiaolei Yao
Glaucoma, a visual thief, is characterized by elevated intraocular pressure (IOP) and the loss of retinal ganglion cells (RGCs). Selecting suitable animals for preclinical models is of great significance in research on the prevention, early screening, and effective treatments of glaucoma. Rabbit eyeballs possess similar vascularity and aqueous humor outflow pathways to those of humans. Thus, they are among the earliest in vivo models used in glaucoma research. Over the years, rabbit models have made substantial contributions to understanding glaucomatous pathophysiology, surgical adaptations, biomedical device development, and drug development for reducing IOP, protecting RGCs, and inhibiting fibrosis. Compared to other animals, rabbits fit better with surgical operations and cost less. This review summarizes the merits and demerits of different ways to produce glaucomatous rabbit models, such as intracameral injection, vortex vein obstruction, Trendelenburg position, laser photo‐coagulation, glucocorticoid induction, limbal buckling induction, retinal ischemia–reperfusion models, and spontaneous models. We analyzed their mechanisms in the hope of providing more references for experimental design and promoting the understanding of glaucoma treatment strategies.

15 July 2025 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
KWKai Wu
Kai Wu
YYYunfeng Yu
Yunfeng Yu
RHRong Hu
Rong Hu
CXCanming Xie
Canming Xie
XYXiaolei Yao
Xiaolei Yao